BioMark Diagnostics Inc.
BUX
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.60K | 25.60K | 103.30K | 115.80K | 237.00K |
| Total Receivables | 49.20K | 49.90K | 22.70K | 31.80K | 35.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | 15.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 110.80K | 75.60K | 125.90K | 147.50K | 288.00K |
|
|
|||||
| Total Current Assets | 110.80K | 75.60K | 125.90K | 147.50K | 288.00K |
| Net Property, Plant & Equipment | 472.50K | 546.60K | 582.00K | 629.00K | 720.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.70K | 25.30K | 25.00K | 25.20K | 10.80K |
| Total Assets | 609.30K | 649.80K | 735.20K | 804.20K | 1.02M |
|
|
|||||
| Total Accounts Payable | 330.60K | 307.80K | 108.80K | 106.70K | 62.00K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 656.10K | 631.00K | 567.40K | 546.40K | 629.40K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 64.20K | 134.30K | 235.20K | 259.80K | 334.00K |
| Total Finance Division Other Current Liabilities | 5.80K | 6.20K | 6.10K | 6.20K | 6.30K |
| Total Other Current Liabilities | 5.80K | 6.20K | 6.10K | 6.20K | 6.30K |
| Total Current Liabilities | 1.06M | 1.08M | 917.60K | 919.00K | 1.03M |
|
|
|||||
| Total Current Liabilities | 1.06M | 1.08M | 917.60K | 919.00K | 1.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 656.10K | 631.00K | 567.40K | 546.40K | 629.40K |
| Capital Leases | 315.60K | 336.20K | 292.30K | 335.40K | 413.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.37M | 1.42M | 1.21M | 1.25M | 1.45M |
|
|
|||||
| Common Stock & APIC | 9.19M | 9.78M | 9.57M | 9.22M | 9.46M |
| Retained Earnings | -10.67M | -11.12M | -10.57M | -9.93M | -9.89M |
| Treasury Stock & Other | 716.10K | 573.60K | 528.90K | 258.50K | -- |
| Total Common Equity | -763.00K | -765.70K | -474.60K | -450.20K | -423.90K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -763.00K | -765.70K | -474.60K | -450.20K | -423.90K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -763.00K | -765.70K | -474.60K | -450.20K | -423.90K |
|
|
|||||